Healthcare provider profile · identity verified

Thomas E. Wolanski, MD

Family Practice · ORANGE, VA · NPI 1881758381

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	528	140
Losartan Potassium	Losartan Potassium	365	86
Lisinopril	Lisinopril	303	73
Omeprazole	Omeprazole	292	77
Amlodipine Besylate	Amlodipine Besylate	267	72
Levothyroxine Sodium	Levothyroxine Sodium	254	55
Metformin Hcl	Metformin Hcl	188	45
Simvastatin	Simvastatin	187	52
Furosemide	Furosemide	165	44
Escitalopram Oxalate	Escitalopram Oxalate	159	39
Gabapentin	Gabapentin	158	47
Rosuvastatin Calcium	Rosuvastatin Calcium	158	40
Metoprolol Succinate	Metoprolol Succinate	156	36
Tamsulosin Hcl	Tamsulosin Hcl	152	38
Hydrochlorothiazide	Hydrochlorothiazide	146	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	146	34
Sertraline Hcl	Sertraline Hcl	137	30
Glimepiride	Glimepiride	131	29
Duloxetine Hcl	Duloxetine Hcl	118	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	105	27
Eliquis	Apixaban	102	19
Carvedilol	Carvedilol	101	29
Allopurinol	Allopurinol	96	23
Irbesartan	Irbesartan	89	26
Montelukast Sodium	Montelukast Sodium	85	27
Meloxicam	Meloxicam	84	21
Pravastatin Sodium	Pravastatin Sodium	84	22
Azithromycin	Azithromycin	81	64
Metformin Hcl Er	Metformin Hcl	81	25
Pantoprazole Sodium	Pantoprazole Sodium	79	26
Trazodone Hcl	Trazodone Hcl	79	26
Tramadol Hcl	Tramadol Hcl	73	18
Albuterol Sulfate Hfa	Albuterol Sulfate	72	30
Prednisone	Prednisone	72	54
Bupropion Xl	Bupropion Hcl	71	12
Lorazepam	Lorazepam	70	11
Jardiance	Empagliflozin	65	16
Pregabalin	Pregabalin	55	17
Zolpidem Tartrate	Zolpidem Tartrate	55	12
Diclofenac Sodium	Diclofenac Sodium	52	15
Alprazolam	Alprazolam	50	suppressed
Synthroid	Levothyroxine Sodium	50	13
Glipizide Er	Glipizide	49	16
Citalopram Hbr	Citalopram Hydrobromide	48	11
Famotidine	Famotidine	47	14
Fluticasone Propionate	Fluticasone Propionate	47	14
Triamcinolone Acetonide	Triamcinolone Acetonide	46	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	11
Donepezil Hcl	Donepezil Hcl	41	11
Metoprolol Tartrate	Metoprolol Tartrate	41	12
Finasteride	Finasteride	39	11
Clopidogrel	Clopidogrel Bisulfate	38	11
Atenolol	Atenolol	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	12
Hydroxyzine Hcl	Hydroxyzine Hcl	34	12
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Cephalexin	Cephalexin	32	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	17
Alendronate Sodium	Alendronate Sodium	31	suppressed
Colchicine	Colchicine	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	23
Potassium Chloride	Potassium Chloride	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	26
Valsartan	Valsartan	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Topiramate	Topiramate	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Baclofen	Baclofen	22	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Mupirocin	Mupirocin	20	12
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ketoconazole	Ketoconazole	19	15
Spironolactone	Spironolactone	19	suppressed
Glipizide	Glipizide	18	suppressed
Ozempic	Semaglutide	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	12
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Amoxicillin	Amoxicillin	15	12
Clonazepam	Clonazepam	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Hydrocortisone	Hydrocortisone	15	suppressed
Indomethacin	Indomethacin	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Chlorthalidone	Chlorthalidone	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Risperidone	Risperidone	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error